Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Inventory Average (2022 - 2025)

Historic Inventory Average for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $482500.0.

  • BioXcel Therapeutics' Inventory Average fell 7705.11% to $482500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $482500.0, marking a year-over-year decrease of 7705.11%. This contributed to the annual value of $1.3 million for FY2024, which is 3284.71% down from last year.
  • As of Q3 2025, BioXcel Therapeutics' Inventory Average stood at $482500.0, which was down 7705.11% from $574000.0 recorded in Q2 2025.
  • In the past 5 years, BioXcel Therapeutics' Inventory Average registered a high of $2.6 million during Q2 2024, and its lowest value of $482500.0 during Q3 2025.
  • Over the past 4 years, BioXcel Therapeutics' median Inventory Average value was $1.8 million (recorded in 2022), while the average stood at $1.6 million.
  • Per our database at Business Quant, BioXcel Therapeutics' Inventory Average surged by 8666.35% in 2023 and then crashed by 7757.37% in 2025.
  • BioXcel Therapeutics' Inventory Average (Quarter) stood at $1.7 million in 2022, then increased by 18.16% to $2.0 million in 2023, then crashed by 45.02% to $1.1 million in 2024, then crashed by 56.22% to $482500.0 in 2025.
  • Its last three reported values are $482500.0 in Q3 2025, $574000.0 for Q2 2025, and $660500.0 during Q1 2025.